Pyxis Oncology, Inc. (PYXS)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 36
+0.13
+5.8296%
$
145.08M Market Cap
- P/E Ratio
- Div Yield
380,400 Volume
-0.91 Eps
$ 2.23
Previous Close 
Want to track PYXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pyxis Oncology, Inc. (PYXS) Statistics
Valuation metrics
Market Cap 145.08M
Enterprise value 160.54M
Trailing P/E (ttm) -1.8
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) 10.79
Price/Book (mrq) 4.79
Enterprise Value/Revenue 11.58
Enterprise Value/EBITDA -2.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 371.43K
Average volume (90 days) 611.43K
Price summary
52-Week low 0.97
52-Week high 5.55
Beta -
50-Day moving average 1.94
200-Day moving average 1.65
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.9%
Operating margin -6.2%
Operational effectiveness
Return on assets -1.27%
Return on equity -1.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.58
Current ratio (mrq) 2.76%
Book value per share (mrq) 0.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
